IL17A and obesity disorder: Also, a direct effect of anti-IL17 inhibitors in obesity is not clearly documented and this is rather troubling for those promoting the hypothesis suggesting that anti-IL17 neutralizing antibodies may indeed have a clinical impact in fighting obesity.